TRENDS IN EMPLOYMENT AND HOSPITALIZATION IN PATIENTS WITH SJOGREN'S SYNDROME 1993-2016: RESULTS FROM THE GERMAN NATIONAL DATABASE

被引：0
|
作者：
Callhoff, Johanna [1 ]
Thiele, Katja [1 ]
Doerner, Thomas [2 ]
Zink, Angela [1 ,2 ]
Henes, Joerg [3 ]
Richter, Jutta [4 ,5 ]
Albrecht, Katinka [1 ]
机构：
[1] German Rheumatism Res Ctr, Epidemiol, Berlin, Germany
[2] Charite, Berlin, Germany
[3] Univ Hosp Tubingen, Rheumatol, Tubingen, Germany
[4] Heinrich Heine Univ, Dept Rheumatol, Dusseldorf, Germany
[5] Heinrich Heine Univ, Hiller Res Unit, Dusseldorf, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.1183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0187
引用
收藏
页码：1168 / 1168
页数：1
相关论文
共 50 条
  • [41] Compromised ultrasound remission, functional ability and clinical decision associated with overlapping Sjogren's syndrome in rheumatoid arthritis patients: results from a propensity-score matched cohort from 2009 to 2019
    Zhang, H.
    Zhang, H.
    Gao, D.
    Zhang, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : S73 - S77
  • [42] Short Bowel Syndrome Is Associated With Increased Morbidity and Health-Care Utilization but Not Mortality in Patients Hospitalized for Crohn's Disease Flare: Analysis From National Inpatient Database
    Basida, Sanket D.
    Nagadia, Urja
    Mansour, Mahmoud
    Gangu, Karthik
    Daglilar, Ebubekir
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S745 - S746
  • [43] Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet’s disease: cross-sectional data of the German National Database 2007–2021
    Jörg Henes
    Jutta G. Richter
    Katja Thiele
    Uta Kiltz
    Johanna Callhoff
    Katinka Albrecht
    Rheumatology International, 2024, 44 : 497 - 507
  • [44] MORTALITY OUTCOME OF ACUTE MYOCARDIAL INFRACTION AND ACUTE HEART FAILURE HOSPITALIZATION IN RHEUMATIC DISEASES PATIENTS PRE-COVID-19 VS. COVID-19 PANDEMIC FROM 2016-2020 NATIONAL INPATIENT SAMPLE (NIS) DATABASE
    Li, Z. Y.
    Huang, S.
    Gokcebel, S.
    Reginato, A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 371 - 372
  • [45] TOP LINE RESULTS FROM NOPRODNAP0017: A DIRECTTO-PATIENT LONGITUDINAL STUDY FOR DIGITAL AND BIOMARKER DISEASE PROFILING OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND SJOGREN'S SYNDROME (PSS)
    Avey, S.
    Reynoso, E.
    Hu, X.
    Ven, K.
    Pandis, I
    Bonet, D.
    Lontoc, T.
    Patel, C.
    Mosca, K.
    Liu, G.
    Morris, M.
    Murphy, P.
    Franks, C.
    Leszczuk, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 39 - 39
  • [46] Association between Parent's Metabolic Syndrome and 12-to18-Year-Old Offspring's Overweight: Results from the Korea National Health and Nutrition Examination Survey (K-NHANES) 2009-2016
    Lee, Na Yeong
    Han, Kyungdo
    Lee, Yoonji
    Kim, Seulki
    Lee, Seonhwa
    Choi, Yujung
    Ahn, Moon Bae
    Kim, Shin Hee
    Cho, Won Kyoung
    Cho, Kyoung Soon
    Jung, Min Ho
    Park, Yong-Gyu
    Suh, Byung-Kyu
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020
  • [47] Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021
    Henes, Joerg
    Richter, Jutta G.
    Thiele, Katja
    Kiltz, Uta
    Callhoff, Johanna
    Albrecht, Katinka
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (03) : 497 - 507
  • [48] IANALUMAB (VAY736) SAFETY AND EFFICACY IN PATIENTS WITH SJOGREN'S SYNDROME: 52 WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL
    Dorner, T.
    Bowman, S. J.
    Fox, R.
    Mariette, X.
    Papas, A.
    Grader-Beck, T.
    Fisher, B. A.
    Barcelos, F.
    De Vita, S.
    Schulze-Koops, H.
    Moots, R. J.
    Junge, G.
    Woznicki, J.
    Sopala, M.
    Luo, W. L.
    Hueber, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 593 - 594
  • [49] IANALUMAB (VAY736) SAFETY AND EFFICACY IN PATIENTS WITH SJOGREN'S SYNDROME: 52 WEEK RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL
    Doerner, T.
    Bowman, S. J.
    Fox, R.
    Mariette, X.
    Papas, A.
    Grader-Beck, T.
    Fisher, B. A.
    Barcelos, F.
    De Vita, S.
    Schulze-Koops, H.
    Moots, R. J.
    Junge, G.
    Woznicki, J.
    Sopala, M.
    Luo, W.
    Hueber, W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 87 - 88
  • [50] Ianalumab (VAY736) Safety and Efficacy in Patients with Sjogren's Syndrome: 52 Week Results from a Randomized, Placebo-controlled, Phase 2b Dose-ranging Trial
    Doerner, Thomas
    Bowman, Simon J.
    Fox, Robert
    Mariette, Xavier
    Papas, Athena
    Grader-Beck, Thomas
    Fisher, Ben A.
    Barcelos, Filipe
    De Vita, Salvatore
    Schulze-Koops, Hendrik
    Moots, Robert
    Junge, Guido
    Woznicki, Janice
    Sopala, Monika
    Luo, Wen-Lin
    Hueber, Wolfgang
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2063 - 2065
12345